Manufacturing / Biological Products, Except Diagnostic Substances
NOVAVAX INC
NVAX
$9.46
+$0.63 (+7.05%)
Price as of Aug 25, 2026 15:53 UTC
1.5 B
Market Cap (Small Cap)
9%
IV Rank
71.7%
Implied Volatility
Nov 04
Next Earnings
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Activity & Greeks
Implied volatility, flow, and dealer positioning from the options market.
Put/Call Ratio
0.48
Bullish skew
Implied Volatility
71.7%
0% percentile
IV vs Realized
Options rich
30d HV 46.3%
Options Heat Map
Delta-risk grid for NVAX options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
0 buys
0 sells
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| Jun 20, 2026 | Alton Gregg H | Exercise | 18,880 | $0 | |
| Jun 20, 2026 | Alton Gregg H | Exercise | 18,880 | $0 | |
| Jun 20, 2026 | MOTT DAVID M | Exercise | 18,880 | $0 | |
| Jun 20, 2026 | MOTT DAVID M | Exercise | 18,880 | $0 | |
| Jun 20, 2026 | MCGLYNN MARGARET G | Exercise | 18,880 | $0 | |
| Jun 20, 2026 | MCGLYNN MARGARET G | Exercise | 18,880 | $0 | |
| Jun 20, 2026 | DOUGLAS RICHARD | Exercise | 18,880 | $0 | |
| Jun 20, 2026 | DOUGLAS RICHARD | Exercise | 18,880 | $0 | |
| Jun 20, 2026 | King Rachel K. | Exercise | 18,880 | $0 | |
| Jun 20, 2026 | King Rachel K. | Exercise | 18,880 | $0 |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 12, 2026 | Q2 2026 | -$0.41 | |||
| Aug 06, 2026 | Q2 2026 | -$0.41 | |||
| Aug 04, 2026 | Q2 2026 | -$0.41 | |||
| Jun 30, 2026 | Q2 2026 | -$0.41 | -$0.32 | +22.6% | Beat |
| Mar 31, 2026 | Q1 2026 | -$0.23 | -$0.06 | +74.5% | Beat |
| Dec 31, 2025 | Q4 2025 | -$0.50 | $0.11 | +122.1% | Beat |
| Sep 30, 2025 | Q3 2025 | -$1.21 | -$1.25 | -3.3% | Miss |
| Jun 30, 2025 | Q2 2025 | -$0.09 | $0.62 | +827.7% | Beat |
Track NVAX with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for NVAX and your entire portfolio.